Business Context and Reporting Period
Company: Alzamend Neuro, Inc. (ALZN)
Filing Type: Form 8-K (Current Report)
Date of Report: October 15, 2024
Reporting Period: Event-based report regarding Nasdaq listing status compliance.
Key Financial Metrics
This filing does not contain specific financial performance data such as revenue, profit, cash flow, margins, or debt levels. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
- Regaining Compliance: On October 14, 2024, the Nasdaq Hearings Panel notified the Company that it has regained compliance with the Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule"), which requires a minimum stockholders' equity of $2,500,000.
- Listing Status: The Panel determined to continue the listing of the Company's securities on The Nasdaq Capital Market and closed the matter.
- Historical Context: The Company was previously notified on September 26, 2023, of non-compliance with the minimum market value of listed securities and the Equity Rule. After failing to regain compliance by the initial March 25, 2024 deadline, the Company successfully appealed and was granted an extension until September 23, 2024.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on October 15, 2024, confirming the demonstration of compliance with the Equity Rule.
Risks and Forward-Looking Statements: The filing includes standard disclaimers regarding forward-looking statements. It notes that actual results may differ materially from anticipated results due to inherent uncertainties and risks. The filing explicitly states that information under Item 7.01 is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the current stockholders' equity balance to confirm it meets or exceeds the $2,500,000 threshold required by Nasdaq Listing Rule 5550(b)(1).
- Review the press release (Exhibit 99.1) for any additional details on the capitalization changes that enabled compliance.
- Monitor future filings to ensure continued compliance with all applicable Nasdaq listing standards beyond the Equity Rule.